United Therapeutics Corp Common
(UTHR)
|
13.8 |
$700M |
|
3.0M |
235.64 |
Argenx Se Sponsored ADR
(ARGX)
|
9.5 |
$480M |
|
1.3M |
378.88 |
Apellis Pharmaceuticals Common
(APLS)
|
8.8 |
$443M |
|
9.8M |
45.22 |
Horizon Therapeutics Common
|
7.9 |
$399M |
|
5.0M |
79.76 |
Mirati Therapeutics Common
|
7.4 |
$373M |
|
5.6M |
67.13 |
Amicus Therapeutics Common
(FOLD)
|
5.7 |
$288M |
|
27M |
10.74 |
Biomarin Pharmaceutical Common
(BMRN)
|
5.4 |
$272M |
|
3.3M |
82.87 |
Seagen Common
|
5.3 |
$270M |
|
1.5M |
176.94 |
Sarepta Therapeutics Common
(SRPT)
|
5.0 |
$254M |
|
3.4M |
74.96 |
Ascendis Pharma Sponsored ADR
(ASND)
|
4.2 |
$212M |
|
2.3M |
92.96 |
Alnylam Pharmaceuticals Common
(ALNY)
|
3.9 |
$198M |
|
1.4M |
145.85 |
Xenon Pharmaceuticals Common
(XENE)
|
2.9 |
$149M |
|
4.9M |
30.42 |
Madrigal Pharmaceuticals Common
(MDGL)
|
2.2 |
$110M |
|
1.5M |
71.58 |
Iovance Biotherapeutics Common
(IOVA)
|
2.0 |
$102M |
|
9.2M |
11.04 |
Kura Oncology Common
(KURA)
|
1.7 |
$88M |
|
4.8M |
18.33 |
Krystal Biotech Common
(KRYS)
|
1.4 |
$71M |
|
1.1M |
65.66 |
Biocryst Pharmaceuticals Common
(BCRX)
|
1.4 |
$69M |
|
6.5M |
10.58 |
Iveric Bio Common
|
1.4 |
$69M |
|
7.1M |
9.62 |
Spdr Series Trust - S&p Biotech Etf
(XBI)
|
1.3 |
$67M |
|
900k |
74.27 |
Ultragenyx Pharmaceutical Common
(RARE)
|
0.9 |
$45M |
|
750k |
59.66 |
Pmv Pharmaceuticals Common
(PMVP)
|
0.9 |
$44M |
|
3.1M |
14.25 |
Syndax Pharmaceuticals Common
(SNDX)
|
0.8 |
$43M |
|
2.2M |
19.24 |
Mersana Therapeutics Common
(MRSN)
|
0.7 |
$35M |
|
7.6M |
4.62 |
Mannkind Corp Common
(MNKD)
|
0.7 |
$35M |
|
9.1M |
3.81 |
Monte Rosa Therapeutics Common
(GLUE)
|
0.6 |
$32M |
|
3.3M |
9.67 |
Design Therapeutics Common
(DSGN)
|
0.6 |
$31M |
|
2.2M |
14.00 |
Cymabay Therapeutics Common
|
0.6 |
$30M |
|
10M |
2.95 |
Kymera Therapeutics Common
(KYMR)
|
0.5 |
$25M |
|
1.3M |
19.69 |
Aadi Biosciences Common
(AADI)
|
0.4 |
$23M |
|
1.8M |
12.32 |
Avidity Biosciences Common
(RNA)
|
0.4 |
$19M |
|
1.3M |
14.53 |
Dice Therapeutics Common
|
0.3 |
$17M |
|
1.1M |
15.52 |
Marinus Pharmaceuticals Common
(MRNS)
|
0.3 |
$15M |
|
3.2M |
4.84 |
Nuvalent Common
(NUVL)
|
0.3 |
$14M |
|
1.0M |
13.56 |
Io Biotech Common
(IOBT)
|
0.2 |
$9.6M |
|
2.1M |
4.67 |
Amarin Corp Sponsored ADR
(AMRN)
|
0.2 |
$8.9M |
|
6.0M |
1.49 |
Tango Therapeutics Common
(TNGX)
|
0.1 |
$7.0M |
|
1.6M |
4.53 |
Fennec Pharmaceuticals Common
(FENC)
|
0.1 |
$6.8M |
|
1.2M |
5.65 |
Relay Therapeutics Common
(RLAY)
|
0.1 |
$6.7M |
|
400k |
16.75 |
Applied Molecular Trans Common
|
0.1 |
$3.0M |
|
1.0M |
2.91 |
Genocea Biosciences Common
(GNCAQ)
|
0.0 |
$86k |
|
5.1M |
0.02 |